Corrigendum to “A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study” [J. Pharm. Biomed. Anal. 166 (2019) 20–29]

2020 ◽  
Vol 181 ◽  
pp. 112627
Author(s):  
Xueting Yao ◽  
Ling Song ◽  
Yang Liu ◽  
Huanhuan Wang ◽  
Jie Liu ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document